Thromb Haemost 1995; 74(02): 784-790
DOI: 10.1055/s-0038-1649813
Scientific and Standardization Committee Communications
Schattauer GmbH Stuttgart

The Reproductive Health of Women with von Willebrand Disease Unresponsive to DDAVP: Results of an International Survey

On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH (H. Gralnick, Chairman)
Paul A Foster
The Blood Research Institute of the Blood Center of Southeastern Wisconsin, Milwaukee, Wl, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
06 July 2018 (online)

Summary

An international registry was established on the reproductive health of women with types of von Willebrand disease (vWd) unresponsive to DDAVP. Data was collected on 44 women from 16 treatment centers in nine countries. Severe menorrhagia requiring blood product therapy occurred at least once in 80% of the women for whom data was reported. Most of the reported episodes occurred prior to the diagnosis of vWd and/or the use of oral contraceptive (OC) therapy. OC therapy was clinically effective in the treatment of chronic menorrhagia in 22 of 25 (88%) women treated. Two of the women, however, were unable to tolerate chronic OC use and a third became refractory to treatment. Hysterectomy was performed in 10 of the 44 women (23%). The reported indication for six of the procedures was menorrhagia. Seventy percent were performed at two treatment centers, suggesting different thresholds for the performance of the procedure. There were 69 pregnancies reported in 31 of the 44 women. Fifteen of the pregnancies resulted in spontaneous abortions. The incidence of miscarriage was 22% and appeared clustered, with 10 of 15 of the miscarriages occurring in just four of the women

 
  • References

  • 1 Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood 1987; 69: 454-459
  • 2 Batlle J, Lopez-Fernandez MF. Von Willebrand disease in Spain and Portugal. Thromb Haemost 1989; 62: 223 (abstract)
  • 3 Nilsson IM. Von Willebrand’s disease from 1926-1983. Scand J Haematol (Suppl) 1984; 33: 21-43
  • 4 Colvin BT, O’Callaghan U, Thomas N. A survey of von Willebrand’s disease in North London. Research in Clinical Laboratories 1986; 16: 236 (abstract)
  • 5 Rodeghiero F, Castaman G, Mannucci PM. Clinical indications for Desmopressin (DDAVP) in congenital and acquired von Willebrand disease. Blood Rev 1991; 5: 155-161
  • 6 Greer IA, Lowe GD O, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 909-918
  • 7 Evans PC. Obstetric and gynecologic patients with von Willebrand’s disease. Obstet Gynecol 1971; 38: 37-43
  • 8 Hill C, Taylor JT. Von Willebrand’s disease in obstetrics and gynaecology. J Obstet Gynaecol Br Cwlth 1968; 75: 453-458
  • 9 Walker EH, Dormandy KM. The management of pregnancy in von Willebrand’s disease. J Obstet Gynaecol Br Cwlth 1968; 75: 459-463
  • 10 Noller KL, Bowie EJ W, Kempers RD, Owen CA. Von Willebrand’s disease in pregnancy. Obstet Gynecol 1973; 41: 865-872
  • 11 Punnonen R, Nyman D, Gronroos M, Wallen O. Von Willebrand’s disease and pregnancy. Acta Obstet Gynecol Scand 1981; 60: 507-509
  • 12 Telfer MC, Chediak J. Factor-VIII-related disorders and their relationship to pregnancy. J Reprod Med 1977; 19: 211-222
  • 13 Lipton RA, Ayromlooi J, Coller BS. Severe von Willebrand’s disease during labor and delivery. JAMA 1982; 248: 1355-1357
  • 14 Conti M, Mari D, Conti E, Muggiasca ML, Mannucci PM. Pregnancy in women with different types of von Willebrand disease. Obstet Gynecol 1986; 68: 282-285
  • 15 Chediak JR, Alban GM, Maxey B. Von Willebrand’s disease and pregnancy: Management during delivery and outcome of offspring. Am J Obstet Gynecol 1986; 155: 618-624
  • 16 Rick ME, Williams SB, Sacher RA, McKeown LP. Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand’s disease. Blood 1987; 69: 786-789
  • 17 Giles AR, Hoogendoom H, Benford K. Type IIB von Willebrand’s disease presenting as thrombocytopenia during pregnancy. Br J Haemotol 1987; 67: 349-353
  • 18 Casonato A, Sartori MT, Bertomoro A, Fede T, Vasoin F, Girolami A. Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand’s disease. Blood Coagul Fibrinolysis 1991; 2: 33-40
  • 19 Takahashi H, Hayashi N, Shibata A. Type IB von Willebrand’s disease and pregnancy: Comparison of analytical methods of von Willebrand factor for classification of von Willebrand’s disease subtypes. Thromb Res 1988; 50: 409-418
  • 20 Apgar BS, Churgay CA. Spontaneous abortion. Prim Care 1993; 20: 621-627
  • 21 Ramsahoye BH, Davies SV, Dasani H. Management of pregnancy and delivery in von Willebrand’s disease. Blood 1993; 82: 584 (abstract)